Ticker Sage

Big-fund tracker · Form 13F

Trian Fund Management’s 13F: what it reported owning at Jun 30, 2026

Trian Fund Management’s stock holdings as reported to the SEC for the quarter ended Jun 30, 2026, compared with the quarter before: top positions, new positions, exits and the biggest changes in shares.

The short answer

Trian Fund Management’s 13F for the quarter ended Jun 30, 2026 lists 8 stock positions with a combined reported value of $4.23B, compared with 8 stock positions worth $3.86B in its filing for the quarter ended Mar 31, 2026. The three largest positions were GE Aerospace, Janus Henderson Group Plc and Solventum, together 82.2% of that value. Against the previous quarter, 0 positions are new, 0 positions are gone, the share count rose in 2, fell in 2 and did not change in 4.

What a 13F shows, and what it doesn't

A 13F is a quarterly report that large investment managers file with the SEC. It is a useful record and a limited one. Read this list before reading the tables.

Positions reported at Jun 30, 2026

All 8 stock positions in the 13F for the quarter ended Jun 30, 2026
#CompanyShares, Jun 30, 2026Shares, Mar 31, 2026Change in sharesChangeReported value, Jun 30, 2026Share of stock positions
1GE AerospaceGE4,030,7654,030,765No change–$1.51B35.6%
2Janus Henderson Group Plc25,654,38231,867,800−6,213,418−19.5%$1.33B31.5%
3SolventumSOLV8,236,7538,236,753No change–$635.5M15.0%
4Ferguson Plc New1,086,3571,086,357No change–$257.8M6.1%
5Wendys Co.30,468,43430,446,022+22,412+0.1%$252.6M6.0%
6GE HealthCareGEHC3,085,3444,044+3,081,300+76,194.4%$197.5M4.7%
7InvescoIVZ1,625,4722,970,944−1,345,472−45.3%$42.9M1.0%
8Magnum Ice Cream Co Nv241,042241,042No change–$4.2M0.1%

One company can have several lines in a 13F (the filer splits a position by the entity that holds it). The lines for the same stock and share class are added together here. Reported value is the filer’s own figure for the position at quarter end. Click any number to open the filing.

What changed from Mar 31, 2026 to Jun 30, 2026

These tables compare this filing with the one for the quarter ended Mar 31, 2026 (filed May 15, 2026). Changes are in shares, from the filings.

Biggest increases in shares, as a percent of the earlier position
CompanyShares, Mar 31, 2026Shares, Jun 30, 2026Change in sharesChangeReported value, Jun 30, 2026
GE HealthCareGEHC4,0443,085,344+3,081,300+76,194.4%$197.5M
Wendys Co.30,446,02230,468,434+22,412+0.1%$252.6M
Biggest reductions in shares, as a percent of the earlier position
CompanyShares, Mar 31, 2026Shares, Jun 30, 2026Change in sharesChangeReported value, Jun 30, 2026
InvescoIVZ2,970,9441,625,472−1,345,472−45.3%$42.9M
Janus Henderson Group Plc31,867,80025,654,382−6,213,418−19.5%$1.33B

Ranked by the percent change in the number of shares, so a small position can top a list. 4 positions had the same number of shares in both filings. A position that is absent from a filing may have been sold in full, or may have been moved to a part of the filer that is reported elsewhere; the filing does not say.

The companies with a Ticker Sage file

4 lines of this 13F are companies Ticker Sage covers, 56.3% of the reported value of the stock positions. Each has its own file built from its 10-K and 10-Q filings.

Covered companies in the 13F for the quarter ended Jun 30, 2026
CompanyShares, Jun 30, 2026Reported value, Jun 30, 2026
GE Aerospace4,030,765$1.51B
Solventum8,236,753$635.5M
GE HealthCare3,085,344$197.5M
Invesco1,625,472$42.9M

Source filings

Both filings are on SEC EDGAR under CIK 0001345471. The next 13F covers the quarter ending Sep 30, 2026 and is due by Nov 14, 2026.

All tracked 13F filers · 13F filings explained · Insider buying · Methodology & Disclosures

Disclosures

Editor holdings
The editor holds no position in any company named on this page. As of Nov 11, 2026.
Compensation
Nobody paid for this page. No affiliate links on this page.
Sources
The Form 13F-HR filings above, linked next to each number.
Last updated
Nov 11, 2026

General education, the same for every reader. This page reports what one filer disclosed. It is not a recommendation to buy, sell or hold any security, and it doesn’t consider your situation.